News from oncimmune A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 09, 2017, 09:00 ET Launch of "Finger Stick" Sample Collection for EarlyCDT®-Lung

Oncimmune USA LLC, the U.S. subsidiary of Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and...


Mar 18, 2016, 03:00 ET Oncimmune Signs Agreement with Accu Reference

U.S.-based clinical laboratory to offer Oncimmune's EarlyCDT®-Lung, a blood test to aid in the risk assessment and early detection of lung cancer...


Mar 03, 2016, 02:00 ET Oncimmune Signs Agreement with Leading Provider of Preventative Health Screenings

U.S.-based Stroke Detection Plus® to offer Oncimmune's EarlyCDT®-Lung, a blood test to aid in the risk assessment and early detection of lung cancer...


Jan 20, 2016, 02:00 ET Oncimmune Appoints Greg Stanley as President of Commercial Operations

Oncimmune, a leader in early cancer detection, today announced the appointment of Greg Stanley as President of Commercial Operations. Greg Stanley is ...


Nov 19, 2015, 02:00 ET Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer

Oncimmune, a leader in early cancer detection, today announced the appointment of Dr James Jett, as Chief Medical Officer. Dr Jett is currently...


Sep 24, 2015, 02:00 ET Oncimmune Acquires Dedicated Commercial Testing Facility for EarlyCDT-Lung from Health Diagnostic Laboratory, Inc

Oncimmune, a leader in early cancer detection, today announces the purchase of substantially all of the assets of Central Medical Laboratory ("CML")...


Sep 08, 2015, 07:30 ET Encouraging Early Results of Major 10,000 Patient National Health Service (NHS) Lung Cancer Screening Trial using EarlyCDT®-Lung Blood Test Announced at the 16th World Conference on Lung Cancer

Encouraging early results from the largest ever randomized trial for lung cancer using autoantibody biomarkers were announced at the International...


May 01, 2012, 07:30 ET National Jewish Health, the Nation's Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT

National Jewish Health (NJH), the # 1 respiratory hospital in the United States, today announces the initiation of a lung cancer screening trial that ...